Author:
Kitadani Junya,Ojima Toshiyasu,Iwamoto Hiromitsu,Tabata Hirotaka,Nakamori Mikihito,Nakamura Masaki,Hayata Keiji,Katsuda Masahiro,Miyajima Masayasu,Yamaue Hiroki
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Steinman, R. M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 9, 271–296 (1991).
2. Nakamura, M. et al. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity. Clin Cancer Res. 8, 2742–2749 (2002).
3. Ojima, T. et al. Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice. Int J Cancer. 120, 585–593 (2007).
4. Ojima, T. et al. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA. Int J Oncol. 32, 459–466 (2008).
5. Miyazawa, M. et al. Dendritic cells adenovirally-transduced with full-length mesothelin cDNA elicit mesothelin-specific cytotoxicity against pancreatic cancer cell lines in vitro. Cancer Lett. 305, 32–39 (2011).
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献